Pesch B - Search Results

1

Are circulating microRNAs suitable for the early detection of malignant mesothelioma? Results from a nested case-control study.

Weber DG, Brik A, Casjens S, Burek K, Lehnert M, Pesch B, Taeger D, Brüning T, Johnen G; MoMar study group. Weber DG, et al. Among authors: pesch b. BMC Res Notes. 2019 Feb 11;12(1):77. doi: 10.1186/s13104-019-4113-7. BMC Res Notes. 2019. PMID: 30744695 Free PMC article.

2

Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer.

Weber DG, Johnen G, Casjens S, Bryk O, Pesch B, Jöckel KH, Kollmeier J, Brüning T. Weber DG, et al. Among authors: pesch b. BMC Res Notes. 2013 Dec 6;6:518. doi: 10.1186/1756-0500-6-518. BMC Res Notes. 2013. PMID: 24313945 Free PMC article.

3

Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis.

Weber DG, Casjens S, Johnen G, Bryk O, Raiko I, Pesch B, Kollmeier J, Bauer TT, Brüning T. Weber DG, et al. Among authors: pesch b. PLoS One. 2014 Dec 3;9(12):e114483. doi: 10.1371/journal.pone.0114483. eCollection 2014. PLoS One. 2014. PMID: 25469901 Free PMC article.

4

Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma.

Weber DG, Gawrych K, Casjens S, Brik A, Lehnert M, Taeger D, Pesch B, Kollmeier J, Bauer TT, Johnen G, Brüning T. Weber DG, et al. Among authors: pesch b. Dis Markers. 2017;2017:9280170. doi: 10.1155/2017/9280170. Epub 2017 Feb 21. Dis Markers. 2017. PMID: 28321148 Free PMC article.

5

Calretinin as a blood-based biomarker for mesothelioma.

Johnen G, Gawrych K, Raiko I, Casjens S, Pesch B, Weber DG, Taeger D, Lehnert M, Kollmeier J, Bauer T, Musk AW, Robinson BWS, Brüning T, Creaney J. Johnen G, et al. Among authors: pesch b. BMC Cancer. 2017 May 30;17(1):386. doi: 10.1186/s12885-017-3375-5. BMC Cancer. 2017. PMID: 28558669 Free PMC article.

6

Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study.

Casjens S, Weber DG, Johnen G, Raiko I, Taeger D, Meinig C, Moebus S, Jöckel KH, Brüning T, Pesch B. Casjens S, et al. Among authors: pesch b. BMJ Open. 2017 Oct 11;7(10):e017104. doi: 10.1136/bmjopen-2017-017104. BMJ Open. 2017. PMID: 29025836 Free PMC article.

7

Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population.

Aguilar-Madrid G, Pesch B, Calderón-Aranda ES, Burek K, Jiménez-Ramírez C, Juárez-Pérez CA, Ochoa-Vázquez MD, Torre-Bouscoulet L, Acosta-Saavedra LC, Sada-Ovalle I, García-Figueroa J, Alvarado-Cabrero I, Castillo-González P, Báez-Saldaña AR, Pérez-Padilla JR, Osnaya-Juárez J, Rivera-Rosales RM, García-Bazán EM, Bautista-Aragón YL, Lazcano-Hernandez E, Munguía-Canales DA, Argote-Greene LM, Taeger D, Weber DG, Casjens S, Raiko I, Brüning T, Johnen G. Aguilar-Madrid G, et al. Among authors: pesch b. Int J Med Sci. 2018 Jun 4;15(9):883-891. doi: 10.7150/ijms.23939. eCollection 2018. Int J Med Sci. 2018. PMID: 30008600 Free PMC article.

8

Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers.

Johnen G, Burek K, Raiko I, Wichert K, Pesch B, Weber DG, Lehnert M, Casjens S, Hagemeyer O, Taeger D, Brüning T; MoMar Study Group. Johnen G, et al. Among authors: pesch b. Sci Rep. 2018 Sep 25;8(1):14321. doi: 10.1038/s41598-018-32315-3. Sci Rep. 2018. PMID: 30254313 Free PMC article.

9

Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma.

Jiménez-Ramírez C, Casjens S, Juárez-Pérez CA, Raiko I, Del Razo LM, Taeger D, Calderón-Aranda ES, Rihs HP, Acosta-Saavedra LC, Weber DG, Cabello-López A, Pesch B, Ochoa-Vázquez MD, Burek K, Torre-Bouscoulet L, Pérez-Padilla JR, García-Bazan EM, Brüning T, Johnen G, Aguilar-Madrid G. Jiménez-Ramírez C, et al. Among authors: pesch b. Lung. 2019 Oct;197(5):641-649. doi: 10.1007/s00408-019-00244-1. Epub 2019 Jul 2. Lung. 2019. PMID: 31267149

10

Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies.

Weber DG, Casjens S, Brik A, Raiko I, Lehnert M, Taeger D, Gleichenhagen J, Kollmeier J, Bauer TT, Brüning T, Johnen G; MoMar study group. Weber DG, et al. Biomark Res. 2020 May 13;8:15. doi: 10.1186/s40364-020-00194-4. eCollection 2020. Biomark Res. 2020. PMID: 32435497 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page